Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT04768244Completed

Impact of Maternal COVID-19 Disease on Breast Milk and Infant Health

Role: collaborator

NCT04280757Unknown

Comparison Between Biopsied and Non-biopsied Intracytoplasmatic Sperm Injection (ICSI) Embryos and Natural Pregnancy Embryos

Role: collaborator

NCT04764461Not ApplicableUnknown

Use of Customized GROW Charts for Detection of SGA in Low Risk Woman.

Role: collaborator

NCT02373839Not ApplicableUnknown

Role of Placental Growth Factor (PlGF) in the Management of Non-Severe Preeclampsia

Role: lead

All 4 trials loaded